![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celoxica | LSE:CXA | London | Ordinary Share | GB00B0L9TZ33 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Celoxica Holdings PLC 11 October 2007 CELOXICA HOLDINGS PLC ("CELOXICA" OR "THE COMPANY") CELOXICA IMPLEMENTS PERFORMANCE ACCELERATION FOR US LIFE-SCIENCES COMPANY Increasing momentum in accelerated computing market Celoxica Holdings plc (AIM: CXA) - a leading provider of FPGA based High Performance Computing solutions, announces the successful implementation of data analysis acceleration in the life sciences environment. Genetic analysis is a fundamental process in modern drug discovery and development but places great demands on data processing. Working with a respected US Life Sciences company, Celoxica was able to accelerate the client's gene sequencing algorithm by a factor of 20, significantly reducing this "bottleneck". The application of Celoxica's technology could have major benefits in the speed and cost of drug development. This follows the announcement last month of two other successful proof of concept projects in the financial services market. Lee Staines, Chief Executive of Celoxica commented, "We are delighted to announce the completion of another successful implementation within one of our key industry verticals. The ever increasing demand for higher performance coupled with a need for a reduction in power consumption is driving momentum in our market. We are seeing an increased level of awareness of our services within the financial services, life-sciences and oil and gas industries and believe the potential for our products to be significant." ENQUIRIES Celoxica Holdings plc (www.celoxica.com) Tel. +44 (0)1235 863 656 Lee Staines, CEO Michelle Young, CFO ICIS Tel. +44 (0) 20 7651 8688 Tom Moriarty +44 (0) 7843 260 623 Caroline Evans-Jones Arbuthnot Tel. +44 (0) 20 7012 2000 Tom Griffiths Alasdair Younie This information is provided by RNS The company news service from the London Stock Exchange END NRAOKKKDABDDOKD
1 Year Celoxica Chart |
1 Month Celoxica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions